Phase 1a/1b study of FPA-150 in patients with solid tumors.
Phase of Trial: Phase I
Latest Information Update: 05 Jan 2018
At a glance
- Drugs FPA 150 (Primary)
- Indications Advanced breast cancer; Endometrial cancer; Ovarian cancer; Solid tumours; Urogenital cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Five Prime Therapeutics
- 05 Jan 2018 New trial record
- 03 Jan 2018 According to the Five Prime Therapeutics media release, company announced the December 2017 submission of an Investigational New Drug (IND) application for FPA150.
- 03 Jan 2018 According to the Five Prime Therapeutics media release, company plans to initiate this trial in first half of 2018.